Technical Analysis for IOBT - IO Biotech, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | -4.27% | |
Calm After Storm | Range Contraction | -4.27% | |
Lower Bollinger Band Walk | Weakness | -4.27% | |
Gapped Up | Strength | -4.27% |
Alert | Time |
---|---|
Possible Inside Day | about 6 hours ago |
Reversed from Down | about 7 hours ago |
60 Minute Opening Range Breakout | about 7 hours ago |
Up 1% | about 7 hours ago |
Gap Down Closed | about 10 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death ligand (PD-L1). It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. IO Biotech, Inc. was incorporated in 2021 and is based in Copenhagen, Denmark.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immune System Treatment Of Cancer Cancer Therapies Anti Cancer Therapies Urea Cycle
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immune System Treatment Of Cancer Cancer Therapies Anti Cancer Therapies Urea Cycle
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.18 |
52 Week Low | 0.8163 |
Average Volume | 108,309 |
200-Day Moving Average | 1.43 |
50-Day Moving Average | 1.34 |
20-Day Moving Average | 1.23 |
10-Day Moving Average | 1.20 |
Average True Range | 0.12 |
RSI (14) | 35.48 |
ADX | 17.97 |
+DI | 10.04 |
-DI | 17.26 |
Chandelier Exit (Long, 3 ATRs) | 1.00 |
Chandelier Exit (Short, 3 ATRs) | 1.38 |
Upper Bollinger Bands | 1.33 |
Lower Bollinger Band | 1.13 |
Percent B (%b) | -0.05 |
BandWidth | 16.00 |
MACD Line | -0.05 |
MACD Signal Line | -0.05 |
MACD Histogram | -0.0035 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.23 | ||||
Resistance 3 (R3) | 1.24 | 1.21 | 1.21 | ||
Resistance 2 (R2) | 1.21 | 1.18 | 1.21 | 1.21 | |
Resistance 1 (R1) | 1.17 | 1.17 | 1.19 | 1.16 | 1.20 |
Pivot Point | 1.14 | 1.14 | 1.15 | 1.13 | 1.14 |
Support 1 (S1) | 1.09 | 1.11 | 1.12 | 1.08 | 1.04 |
Support 2 (S2) | 1.06 | 1.09 | 1.06 | 1.03 | |
Support 3 (S3) | 1.02 | 1.06 | 1.03 | ||
Support 4 (S4) | 1.01 |